The U.S. Food and Drug Administration (FDA) has permanently appointed leaders to four critical regulatory positions, including a new director for drug oversight, following the confirmation of a senior official. The agency announced the transitions after naming a permanent head, with acting officials stepping into their roles permanently. Among the appointees is a psychiatrist taking over drug regulation responsibilities, while other key posts overseeing vaccines and tobacco products will also see permanent leadership. The moves mark a significant shift in the FDA’s top-tier management structure.
The Trump administration permanently filled four key leadership roles in the Food and Drug Administration (FDA) on Tuesday, the agency announced, following the nomination of Heidi Overton to lead the FDA. The acting leaders in charge of regulating drugs, vaccines and tobacco will transition into the jobs permanently. Michael Davis, a psychiatrist, will be director...
